Bruker Corporation (BRKR) Releases Earnings Results, Reports EPS of $0.20 EPS

Bruker Corporation (BRKR) reported quarterly earnings results on Tuesday, Aug-2-2016. The company reported $0.20 EPS for the quarter. Analysts had a consensus estimate of $0.20. The company posted revenue of $371.70 million in the period, compared to analysts expectations of $410.42 million. The company’s revenue was down -6.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.19 EPS.

Many Wall Street Analysts have commented on Bruker Corporation. Company shares were Reiterated by Mizuho on May 5, 2016 to “Neutral”, Firm has raised the Price Target to $ 28 from a previous price target of $22 .Company shares were Reiterated by Barclays on May 5, 2016 to “Overweight”, Firm has raised the Price Target to $ 32 from a previous price target of $30 .

Bruker Corporation opened for trading at $24.47 and hit $24.98 on the upside on Friday, eventually ending the session at $24.92, with a gain of 1.80% or 0.44 points. The heightened volatility saw the trading volume jump to 7,34,241 shares. Company has a market cap of $4,023 M.

In a different news, on Jun 15, 2016, Frank H Laukien (CEO) purchased 4,174 shares at $23.95 per share price. According to the SEC, on May 11, 2016, Brenda J Furlong (director) sold 22,600 shares at $27.43 per share price. On May 11, 2016, Wolf-dieter Emmerich (director) sold 21,000 shares at $27.35 per share price, according to the Form-4 filing with the securities and exchange commission.

Bruker Corporation is a designer and manufacturer of life science and materials research systems and associated products that address the needs of a range of customers in life science research pharmaceuticals applied markets nanotechnology cell biology clinical research microbiology and in-vitro diagnostics. The Company operates through two segments: Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST). BSI is organized into three operating segments: the Bruker BioSpin Group the Bruker CALID Group and the Bruker Nano Group. BEST designs manufactures and distributes superconducting materials. The company maintains technical and manufacturing centers in Europe and North America and it has sales offices located throughout the world.

Bruker Corporation

Leave a Reply

Bruker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Bruker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.